Re: Tweet from Prof Kausik Ray
|
9
|
Resverlogix Corp.
|
Jun 02, 2020 09:42AM
|
Re: Denali Therapeutics unveils BBB delivery system
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 01, 2020 09:58AM
|
Re: News! - COVID 19 pre-clinical and clinical research trials
|
4
|
Resverlogix Corp.
|
Jun 01, 2020 09:39AM
|
Resverlogix Plans COVID-19 Clinical Trial Program Launch
|
6
|
Resverlogix Corp.
|
Jun 01, 2020 09:38AM
|
Re: Denali Therapeutics unveils BBB delivery system
|
3
|
BIOASIS TECHNOLOGIES INC
|
May 28, 2020 12:46PM
|
Denali Therapeutics unveils BBB delivery system
|
2
|
BIOASIS TECHNOLOGIES INC
|
May 27, 2020 09:33PM
|
The therapeutic potential of BRD4 in cardiovascular disease
|
7
|
Resverlogix Corp.
|
May 20, 2020 08:10AM
|
BioRxiv article on Mtfp-siRNA
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 18, 2020 10:23AM
|
Re: AACR virtual meeting June22nd
|
|
Zenith Epigenetics
|
May 18, 2020 09:29AM
|
Re: AACR virtual meeting June22nd
|
4
|
Zenith Epigenetics
|
May 17, 2020 07:43AM
|
Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes
|
6
|
Resverlogix Corp.
|
May 08, 2020 02:20PM
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 11:45AM
|
Re: https://scr.zacks.co...
|
5
|
Zenith Epigenetics
|
May 04, 2020 11:39AM
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 11:33AM
|
Re: 2 new upcoming presentations
|
2
|
Resverlogix Corp.
|
May 04, 2020 07:50AM
|
Re: 2 new upcoming presentations
|
2
|
Resverlogix Corp.
|
May 03, 2020 04:59PM
|
Re: 2 new upcoming presentations
|
2
|
Resverlogix Corp.
|
May 03, 2020 04:55PM
|
Re: From 2018.
|
3
|
Resverlogix Corp.
|
May 03, 2020 12:09PM
|
Re: 2 new upcoming presentations
|
3
|
Resverlogix Corp.
|
May 03, 2020 12:06PM
|
Re: SO078 APABETALONE, A BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES ALKALINE PHOSPHATASE IN CVD PATIENTS....
|
3
|
Resverlogix Corp.
|
May 03, 2020 12:01PM
|